'Asymptomatic patients' presentation slideshows

TOXICOLOGY: ANTIDEPRESSANTS & ANTIPSYCHOTICS

TOXICOLOGY: ANTIDEPRESSANTS & ANTIPSYCHOTICS . May 26, 2011 Jason Mitchell Joe McLellan Phil Ukrainetz. INTRODUCTION. 18 yo F 1/52 Fever, otalgia, chills, myalgia, arthralgia Tooth extraction 2/52 ago Meds: Percodan (ASA/Oxycodone) Chlorphenamine Erythromycin

926 views • 65 slides

Why sleep?

Why sleep?. The origins and development of Sleep Medicine A.W.A.K.E. NOVEMBER 4, 2009. light. 2007 Grand Rounds RIH . How many of you would aggressively treat HTN in a patient with a TIA or stroke? How many of you would treat a hypercoaguable state in a patient with a TIA or stroke?

901 views • 62 slides

PAOLO CARLINI Oncologia Medica A Dipartimento di Oncologia Medica

PAOLO CARLINI Oncologia Medica A Dipartimento di Oncologia Medica. Classification scheme for prostate cancer based on hormonal sensitivity (Scher HI et al. Urology 1995;46:142-48). CRPC definition. FDA Regulatory Approvals in Metastatic CRPC. Estramustine-1981 Ancient History

976 views • 62 slides

AORTIC STENOSIS AND MITRAL VALVE PROLAPSE

AORTIC STENOSIS AND MITRAL VALVE PROLAPSE. PRESENTED BY: FADAIRO OLUMAYOWA BEATRICE 692. AORTIC STENOSIS.

1.01k views • 62 slides

Enzyme-linked immunosorbent assay

912 views • 48 slides

Prostate Cancer

Prostate Cancer. Robert R. Zaid D.O Family Medicine 6/23/2010. Practice Management Moment. How can you expand your practice using social history?. Prostate Cancer Definition. Relevance Most common noncutaneous malignancy in men Incidence Nearly 200,000 new cases per year in U.S.

1.8k views • 42 slides

IN THE NAME OF GOD

IN THE NAME OF GOD . Autoimmune hepatitis. DR. n. aLETAHA MD. INTRODUCTION. Autoimmune hepatitis is a chronic hepatitis of unknown etiology that occurs in children and adults of all ages.

619 views • 41 slides

Sorting out the Diagnostics

Sorting out the Diagnostics. Ed Marino, PA-C Porter Adventist Hospital Liver Transplant Services Denver, CO. Acknowledgements. Thanks to the organizers for my invitation Especially Corinna Dan, RN, MPH Staff at Hepatitis Foundation International

569 views • 40 slides

Sorting out the Diagnostics

Sorting out the Diagnostics. Ed Marino, PA-C Porter Adventist Hospital Liver Transplant Services Denver, CO. Acknowledgements. Thanks to the organizers for my invitation Especially Corinna Dan, RN, MPH Staff at Hepatitis Foundation International

511 views • 40 slides

Sarcoidosis

Sarcoidosis. T. Lianne Beck, MD Assistant Professor Emory Family & Preventive Medicine. Objectives. Epidemiology Pathogenesis Clinical presentation Organ systems involved Diagnostic evaluation Current evidence on treatment. Sarcoidosis.

1.36k views • 30 slides

Hyperparathyroidism

Hyperparathyroidism. PTH/Calcium Homeostasis.

611 views • 30 slides

Joint Hospital Surgical Grand Round 21 Dec 2002 Management of Gallbladder Polyps Dr David IP Shing Fai Department of Sur

Joint Hospital Surgical Grand Round 21 Dec 2002 Management of Gallbladder Polyps Dr David IP Shing Fai Department of Surgery United Christian Hospital. What is a Polypoid Lesion of Gallbladder? PLG. Any elevated lesions of the mucosal surface of the gallbladder wall

1.08k views • 28 slides

Management of substernal goiter

Management of substernal goiter. UCH KH Tse. Clinical scenario. 70/F Asymptomatic. Refer for your expert opinion. Questions. What is the diagnosis ? How do you manage ?. Introduction. SSG First described by Haller in 1749. Account for 10-15% of all the mediastinal mass.

1.46k views • 27 slides

SCREENING AND SAFETY IN IBOGAINE PATIENTS

470 views • 22 slides

SCREENING AND SAFETY IN IBOGAINE PATIENTS

361 views • 22 slides

Panel Questions-Clinical Trial Design

Panel Questions-Clinical Trial Design. 1. Can the data from the investigator-sponsor studies be considered in the evaluation of high risk stenting given the differences in trial conduct for the high-risk investigator-sponsor registries?. Panel Questions-Clinical Trial Design.

408 views • 17 slides

Aggrenox

Aggrenox. Is it as good as the ads?. Multicentre, randomized, double-blind, placebo-controlled trial 6,602 patients randomized within 3 months of qualifying event (TIA or stroke) Treatment and follow-up time: 2 years Visits at 1 month and 3 months, then at 3-month intervals.

596 views • 15 slides

Michael S. Saag, MD

194 views • 6 slides

ABSTRACT

109 views • 1 slides

Modern assessment of lung disease

Modern assessment of lung disease. Dr Alex Horsley NIHR Clinician Scientist Senior Lecturer, University of Manchester Honorary Consultant, Manchester Adult CF Centre. Multiple breath washout. Follow the concentration of an inert tracer gas washed from the lungs during tidal breathing

164 views • 0 slides